⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29312354 | 0.72 | — | — | |
| SCHEMBL10697505 | 0.71 | — | — | |
| SCHEMBL3227420 | 0.71 | — | — | |
| SCHEMBL24434460 | 0.71 | — | — | |
| SCHEMBL236882 | 0.70 | — | — | |
| SCHEMBL10573897 | 0.69 | MEN1 (0.33) | — | |
| Bromide SCHEMBL29035873 | 0.68 | — | — | |
| SCHEMBL11672723 | 0.67 | — | — | |
| SCHEMBL14225509 | 0.66 | SLC6A3 (0.36) | — | |
| SCHEMBL21437122 | 0.66 | MEN1 (0.37) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190040057-A1 | HETEROARYL CARBOXAMIDES | BAYER HEALTHCARE AG (DE) | 2019-02-07 | — | — | US | disclosed |
| US-9926311-B2 | Heteroaryl carboxamides | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2018-03-27 | — | — | US | disclosed |
| US-20160214975-A1 | HETEROARYL CARBOXAMIDES | BAYER HEALTHCARE AG (DE) | 2016-07-28 | — | — | US | disclosed |
| US-9139579-B2 | Heteroaryl carboxamides | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2015-09-22 | — | — | US | disclosed |
| US-20130144062-A1 | HETEROARYL CARBOXAMIDES | Bayer Pharma AG (DE) | 2013-06-06 | — | — | US | disclosed |
| US-8227598-B2 | Heteroaryl carboxamides | BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) | 2012-07-24 | — | — | US | disclosed |
| US-20080009624-A1 | Heteroaryl carboxamides | BAYER HEALTHCARE AG (DE) | 2008-01-10 | — | — | US | disclosed |
| US-7256288-B2 | Heteroaryl carboxylic acid amides | BAYER HEALTHCARE AG (DE) | 2007-08-14 | — | — | US | disclosed |
| US-20050209236-A1 | Heteroaryl carboxylic acid amides | BAYER PHARMA AKTIENGESELLSCHAFT (DE) | 2005-09-22 | — | — | US | disclosed |
| EP-0272446-B1 | NOVEL ANTIVIRAL AGENTS | SRI INTERNATIONAL (US) | 1992-11-11 | — | — | EP | disclosed |
| EP-0145739-B1 | NOVEL ANTIVIRAL AGENTS | SRI INTERNATIONAL (US) | 1989-02-08 | — | — | EP | disclosed |